CLINICAL_TRIALS
trial_result
· 2020-12-29
Clinical Trial Update: MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma [Phase 1, Phase 2]
Summary
Clinical trial update for MLN0128 in recurrent/metastatic Merkel cell carcinoma (Phase 1/Phase 2) completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Merkel Cell Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-12-29